ONCOFUSE MED

About ONCOFUSE MED

A medical device company delivering an end-to end  solution that makes transport, administration and waste management of radioligand therapies scalable, safe and sustainable.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Austria
  • On CPHI since:
    2025
  • Employees:
    1 - 24
Company types
Drug delivery device Supplier/Manufacturer
Start-up
Contact info
Show contact info Hide contact info

Products from ONCOFUSE MED (2)

  • Safeguard Radioligand Therapy System

    Product Safeguard Radioligand Therapy System

    The Safeguard Radioligand Therapy System is an integrated, end-to-end medical device solution designed to make radioligand therapy scalable, safe, and sustainable across the full care pathway—from transport and administration to waste management. Built to address the operational and safety challenges that...
  • Safeguard Radioligand Therapy System SRTS

    Product Safeguard Radioligand Therapy System SRTS

    The SRTS is a device for transport, administration, and waste management of radioactive substances. This device is designed to enable the safe handling and administration of radiotherapeutic agents by providing effective shielding against ionizing radiation.With the expected increased use of Radioligand Th...